nirayu limited's most recent trade in Alembic Pharmaceuticals Ltd. was a Acquisition of 10,000 Equity Shares done at an average price of Rs. 903.5 . Disclosure was reported to the exchange on Oct. 1, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for nirayu limited in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharma | Nirayu Private Limited | Promoter Group | Acquisition | 01 Oct 2025 | 10,000 | 70,070,700 (35.65%) | 0.01% | 903.5 | 9,035,483 | 29 Sep 2025 29 Sep 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Alembic Pharma | Nirayu Private Limited | Promoter Group | Acquisition | 29 Sep 2025 | 5,000 | 70,060,700 (35.64%) | 0.00% | 901.8 | 4,508,921 | 26 Sep 2025 26 Sep 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Alembic Pharma | NIRAYU LIMITED | Promoter Group | Acquisition | 28 Mar 2025 | 12,665 | 70,055,700 (35.64%) | 0.01% | 905.1 | 11,463,509 | 27 Mar 2025 28 Mar 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Alembic Pharma | NIRAYU LIMITED | Promoter Group | Acquisition | 24 Mar 2025 | 7,600 | 70,043,035 (35.63%) | 0.00% | 866.7 | 6,587,236 | 21 Mar 2025 21 Mar 2025 |
Insider Trading | Equity Shares | Market Purchase |